French public sceptical of pharma but still has faith in medicines after Mediator scandal
This article was originally published in Scrip
Executive Summary
It cannot come as much of a surprise, -in the wake of the Mediator scandal that has gripped France, that the French public believes that the pharmaceutical industry is more concerned about profit than sick patients, according to a study conducted by the French R&D-based industry association, Leem. Nevertheless, reassuringly for industry, patients still trust in their medicines.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.